BSEAchyut Healthcare Limited· Pharmaceuticals & BiotechnologyMinimalNeutral
Announced Mon, 26 Oct, 2026 · 18:05 IST

No deviation in use of public and preferential issue proceeds

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.9%Reaction day
₹7.30
prior close
₹6.94
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+3.2% vs market
Pharmaceuticals peers, median of 173sector+2.0%+3.0% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.9+1.7+3.2+2.0+3.0
Next day
+10.1+1.8+8.3+2.6+7.5
2d
+9.6pendingpending+2.6+6.9
3d
———+1.9—
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the quarter and half-year ended 30 September 2026, Achyut Healthcare confirmed no deviation from the approved use of funds. The filing covers Rs 360 lakh raised through a public issue and preferential issues of Rs 520.80 lakh, Rs 1,572.48 lakh and Rs 348 lakh. Allocations remained aligned with the stated objects.

Likely market impact

Neutral for shareholders: proceeds were used as approved, with no change in plans or diversion of funds.